We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byJustin Daniels
Modified over 5 years ago
Solange Arazi Caillaud. MD Emiliano Bissio. MD María Ester Lázaro. MD
99% of men love Football 99% of what she says about us, is unfortunatly true Less than 30% of argentines dance tango 80% of argentines drink mate
Total Population 40 Millions HIV infected 120 000 People who know their HIV status 60 000 (50%) People on follow up 56 000 69% public health 31% security system
DISTRIBUTION OF HIV INFECTED PATIENTS ARGENTINA- 2008 Buenos Aires city and suburbs: 44% Central Area: 27%
Routes of transmission Argentina (2005-2008) MenWomen 48% 34% 87%
CD4 Viral load Resistance test PCR-HIV(MTCT) ARV Drugs for treatment and prophylaxis of opportunistic infections NRTI Zidovudine Lamivudine Stavudine Didanosine Tenofovir Abacavir Emtricitabine+ tenofovir NNRTI Nevirapine Efavirenz Etravirine PI Nelfinavir Indinavir Ritonavir Saquinavir Amprenavir Lopinavir+ritonavir Fosamprenavir Tipranavir Atazanavir Darunavir Integrase Inhibitor Raltegravir Co-Receptor antagonist Maraviroc Fusion Inhibitor Enfuvirtide ( T20)
Rate of MTCT per 10000 newborn Age at diagnosis of the children perinatally infected. N= 3898 67% 2 years old Number of children Age (years)
Thanks EACS for this great oportunity!
International Antiviral SocietyUSA Panel
Management of ART in Albania : From the European Guidelines to the real practice. Arjan Harxhi MD, MSc, PhD University Hospital Center of Tirana Mother.
HIV Situation in India Dr Sunil Gaikwad.
HIV/AIDS in Argentina Vanesa Fridman, MD Infectious Disease Hospital de Clinicas Universidad de Buenos Aires, Argentina.
Insight into Hungarian HIV situation 9th Advanced HIV Course, EACS , Aix en Provence Botond Lakatos, HU.
Ministry of Health National STD/AIDS Programme Universal Access to Antiretroviral Therapy: The Brazilian Experience.
Development of Pediatric ARV Drugs – FDA Perspective
Seafarers and HIV infection
ARV failure and resistance for the paediatrician
Innovative Strategies for the Management of HIV Infection Dual therapies without NRTIs Jean-Guy Baril, MD Clinique médicale du Quartier Latin CHUM This.
Slide #1 HIV Entry Inhibitors Trip Gulick, MD, MPH Director, Cornell HIV Clinical Trials Unit Associate Professor of Medicine Weill Medical College of.
Pre Test !!!!!!. How many classes of HIV meds are currently available?
Antiretroviral drugs in UMMC Presenter: TE CHIN YEW Preceptor: KHOO SU LIN.
Developing child-appropriate formulations: what is in the research pipeline for paediatric ARVS? July 17, 2011 Challenges in the Development & Procurement.
The Medicines Patent Pool advancing innovation, expanding access, promoting public health Charles Clift Chair, Medicines Patent Pool
HIV Treatment and Intellectual Property Rights: The Experience of the Medicines Patent Pool Esteban Burrone Melbourne – International AIDS Conference July.
MONITORING SYSTEM FOR THE ANTIRETROVIRAL THERAPY IN BRAZIL: LESSONS LEARNED AND FUTURE DIRECTIONS Marco Vitória, MD Brazilian STD/AIDS Programme - MOH.
Fabio Mesquita, MD, PhD Director of the Brazilian Ministry of Health’s HIV/AIDS and Viral Hepatitis Department July 20th, 2014 Evidence.
Rodrigo Zilli Haanwinckel Ministry of Health of Brazil Health Surveillance Secretariat Department of STD, AIDS and Hepatitis Prevention of vertical transmission.
Initiating Antiretroviral Therapy in Treatment-Naive Patients Charles B. Hicks, MD Associate Professor of Medicine, Division of Infectious Diseases and.
© 2019 SlidePlayer.com Inc. All rights reserved.